Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept.

OBJECTIVE We sought to determine whether damage after deep hypothermic circulatory arrest can be diminished by changing pump prime components when reinstituting cardiopulmonary bypass. METHODS Fifteen piglets (2-3 months old) were cooled to 19 degrees C by using the alpha-stat pH strategy. Five were cooled and rewarmed without ischemia (control animals), and the other 10 piglets underwent 90 minutes of deep hypothermic circulatory arrest. Of these, 5 were rewarmed and reperfused without altering the cardiopulmonary bypass circuit blood prime. In the other 5 animals, the bypass blood prime was modified (leukocyte depleted, hypocalcemic, hypermagnesemic, pH-stat, normoxic, mannitol, and an Na(+)/H(+) exchange inhibitor) during circulatory arrest before starting warm reperfusion. Oxidant injury was assessed on the basis of conjugated dienes, vascular changes on the basis of endothelin levels, myocardial function on the basis of cardiac output and dopamine need, lung injury on the basis of pulmonary vascular resistance and oxygenation, and cellular damage on the basis of release of creatine kinase and aspartate aminotransferase. Neurologic assessment (score 0, normal; score 500, brain death) was done 6 hours after discontinuing cardiopulmonary bypass. RESULTS Compared with animals undergoing cardiopulmonary bypass without ischemia (control animals), deep hypothermic circulatory arrest without modification of the reperfusate produced an oxidant injury (conjugated dienes increased 0.78 vs 1.71 absorbance (Abs) 240 nmol/L per 0.5 mL, P <.001 vs control animals), depressed cardiac output (6.0 vs 4.0 L/min, P <.05 vs control subjects), prolonged dopamine need (P <.001 vs control subjects), elevated pulmonary vascular resistance (74% vs 197%, P <.05 vs control subjects), reduced oxygenation (P <.01 vs control subjects), increased neurologic injury (56 vs 244, P <.001 vs control subjects), and increased release of creatine kinase (2695 vs 6974 U/L, P <.05 vs control subjects), aspartate aminotransferase (144 vs 229 U/L), and endothelin (1.02 vs 2.56 pg/mL, P <.001 vs control subjects). Conversely, the oxidant injury was markedly limited (conjugated dienes of 0.85 +/- 0.09 Abs 240 nmol/L per 0.5 mL, P <.001 vs unmodified pump prime) with modification of cardiopulmonary bypass prime, resulting in increased cardiac output (5.1 +/- 0.8 L/min), minimal dopamine need (P <.001 vs unmodified pump prime), no increase in pulmonary vascular resistance (44% +/- 31%, P <.01 vs unmodified pump prime) or endothelin levels (0.64 +/- 0.15 pg/mL, P <.001 vs unmodified pump prime), complete recovery of oxygenation (P <.01 vs unmodified pump prime), reduced neurologic damage (144 +/- 33, P <.05 vs unmodified pump prime), and lower release of aspartate aminotransferase (124 +/- 23 U/L, P <.05 vs unmodified pump prime) and creatine kinase (3366 +/- 918, P <.05 vs unmodified pump prime). CONCLUSIONS A global reperfusion injury after deep hypothermic circulatory arrest was identified and changed. The injury is mediated by oxygen-derived free radicals, resulting in organ and endothelial dysfunction. Modification of global organ and endothelial damage is achieved by modifying the blood prime in the cardiopulmonary bypass circuit to deliver a controlled global reperfusate when reinstituting bypass.

[1]  D. Wypij,et al.  Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. , 2001, The Journal of thoracic and cardiovascular surgery.

[2]  Jeffrey A. Golden,et al.  Comparison of neurologic outcome after deep hypothermic circulatory arrest with alpha-stat and pH-stat cardiopulmonary bypass in newborn pigs. , 2001, The Journal of thoracic and cardiovascular surgery.

[3]  R. Jonas Optimal pH strategy for hypothermic circulatory arrest. , 2001, The Journal of thoracic and cardiovascular surgery.

[4]  James L. Park,et al.  Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction , 2001, Perfusion.

[5]  B. Allen,et al.  Hypoxia, reoxygenation and the role of systemic leukodepletion in pediatric heart surgery , 2001, Perfusion.

[6]  B. Allen,et al.  Pediatric myocardial protection: an overview. , 2001, Seminars in thoracic and cardiovascular surgery.

[7]  V. Vainionpää,et al.  Leukocyte filtration improves brain protection after a prolonged period of hypothermic circulatory arrest: A study in a chronic porcine model. , 2000, The Journal of thoracic and cardiovascular surgery.

[8]  B. Allen,et al.  Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic reperfusate. , 2000, The Annals of thoracic surgery.

[9]  B. Allen,et al.  Lowering reperfusion pressure reduces the injury after pulmonary ischemia. , 2000, The Annals of thoracic surgery.

[10]  G. Buckberg,et al.  Superiority of magnesium cardioplegia in neonatal myocardial protection. , 1999, The Annals of thoracic surgery.

[11]  B. Allen,et al.  L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts. , 1999, The Journal of thoracic and cardiovascular surgery.

[12]  J. Bucerius,et al.  Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. II. hypoxic versus free radical injury. , 1999, The Journal of thoracic and cardiovascular surgery.

[13]  J. Bucerius,et al.  Oxygenation strategy and neurologic damage after deep hypothermic circulatory arrest. I. Gaseous microemboli. , 1999, The Journal of thoracic and cardiovascular surgery.

[14]  B. Allen,et al.  Controlled reperfusion prevents pulmonary injury after 24 hours of lung preservation. , 1998, The Annals of thoracic surgery.

[15]  P. Herijgers,et al.  Na+/H+ exchange inhibition improves long-term myocardial preservation. , 1998, The Annals of thoracic surgery.

[16]  G. Buckberg,et al.  Prevention of Ischemic Damage Using Controlled Limb Reperfusion , 1998, Journal of cardiac surgery.

[17]  B. Allen,et al.  Controlled reperfusion after lung ischemia: implications for improved function after lung transplantation. , 1998, The Journal of thoracic and cardiovascular surgery.

[18]  B. Allen,et al.  Detrimental effects of cardiopulmonary bypass in cyanotic infants: preventing the reoxygenation injury. , 1997, The Annals of thoracic surgery.

[19]  E. Verrier,et al.  Ischemia-Reperfusion Injury , 1997 .

[20]  B. Allen,et al.  Myocardial protection in normal and hypoxically stressed neonatal hearts: the superiority of hypocalcemic versus normocalcemic blood cardioplegia. , 1996, The Journal of thoracic and cardiovascular surgery.

[21]  F. Sjöberg,et al.  Adverse effects of hyperoxemia during cardiopulmonary bypass. , 1996, The Journal of thoracic and cardiovascular surgery.

[22]  T. Miura,et al.  University of Wisconsin cerebroplegia in a piglet survival model of circulatory arrest. , 1995, The Annals of thoracic surgery.

[23]  G. Buckberg,et al.  Studies of hypoxemic/reoxygenation injury: without aortic clamping. III. Comparison of the magnitude of damage by hypoxemia/reoxygenation versus ischemia/reperfusion. , 1995, The Journal of thoracic and cardiovascular surgery.

[24]  G. Buckberg Studies of hypoxemic/reoxygenation injury: I. Linkage between cardiac function and oxidant damage. , 1995, The Journal of thoracic and cardiovascular surgery.

[25]  J. Bailey,et al.  Pediatric Cardiopulmonary Bypass , 1995 .

[26]  W. Williams,et al.  Hypothermia, Cardiac Surgery, and Cardiopulmonary Bypass , 1995 .

[27]  M. Cambillau,et al.  Improvement of postischemic kidney function by reperfusion with a specifically developed solution (BT01). , 1995, Annals of vascular surgery.

[28]  M. Karmazyn,et al.  Comparative Effects of Na+/H+ Exchange Inhibitors Against Cardiac Injury Produced by Ischemia/Reperfusion, Hypoxia/Reoxygenation, and the Calcium Paradox , 1993, Journal of cardiovascular pharmacology.

[29]  A. Baue,et al.  Glenn's Thoracic and Cardiovascular Surgery , 1991 .

[30]  F. Beyersdorf,et al.  Avoiding reperfusion injury after limb revascularization: experimental observations and recommendations for clinical application. , 1989, Journal of vascular surgery.

[31]  G. Buckberg Strategies and logic of cardioplegic delivery to prevent, avoid, and reverse ischemic and reperfusion damage. , 1987, The Journal of thoracic and cardiovascular surgery.

[32]  G. Buckberg,et al.  Immediate functional recovery after six hours of regional ischemia by careful control of conditions of reperfusion and composition of reperfusate. , 1986, The Journal of thoracic and cardiovascular surgery.